BFC Planning, Inc.’s AbbVie ABBV Stock Holding History

BFC Planning, Inc.’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.8M	Sell	50,764 -430	-0.8%	-$92.5K	0.52%	31
2026 Q1	$11.1M	Buy	51,194 +828	+2%	+$184K	0.5%	30
2025 Q4	$11.5M	Buy	50,366 +13,096	+35%	+$2.98M	0.51%	35
2025 Q3	$8.63M	Buy	37,270 +799	+2%	+$163K	0.62%	25
2025 Q2	$6.77M	Buy	36,471 +745	+2%	+$138K	0.53%	34
2025 Q1	$7.48M	Sell	35,726 -294	-0.8%	-$57.2K	0.66%	21
2024 Q4	$6.4M	Buy	+36,020	New	+$6.62M	0.53%	35

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFC Planning, Inc.'s ABBV Position: Q2 2026 in Review

BFC Planning, Inc. reduced its AbbVie (ABBV) stake by 0.84% in Q2 2026, selling an estimated $92.5K and leaving 50,764 shares worth $12.8M. The position accounts for 0.52% of the portfolio, ranked #31.

BFC Planning, Inc. first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,249 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

BFC Planning, Inc. held 50,764 shares of AbbVie worth $12.8M as of Q2 2026.
BFC Planning, Inc. sold 430 AbbVie shares in Q2 2026, an estimated $92.5K.
AbbVie made up 0.52% of BFC Planning, Inc.'s portfolio in Q2 2026, its #31 holding.
BFC Planning, Inc. first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,249 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.